{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:08:33Z","timestamp":1774282113020,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Research Project of Jiangsu Health Commission, China","award":["2024015"],"award-info":[{"award-number":["2024015"]}]},{"name":"Science and Technology Support Program (Social Development) Project of Taizhou City, China","award":["202416"],"award-info":[{"award-number":["202416"]}]},{"name":"the Taizhou sixth phase 311 talent training projec","award":["202421"],"award-info":[{"award-number":["202421"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04682-z","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:56:43Z","timestamp":1771066603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Galectin-1 and peritoneal fibrosis: a novel predictor for peritoneal metastasis in gastric cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Chuanjiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzhu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chungen","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"issue":"9","key":"4682_CR1","doi-asserted-by":"publisher","first-page":"6028","DOI":"10.1245\/s10434-024-15613-1","volume":"31","author":"B Canbay Torun","year":"2024","unstructured":"Canbay Torun B, Sobutay E, Eren Akbulut O, Saglam S, Yilmaz S, Yonemura Y, Canbay E. ASO author reflections: important predictive factors for prognosis in patients with peritoneal metastasis of GC. Ann Surg Oncol. 2024;31(9):6028\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"4682_CR2","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1245\/s10434-024-15592-3","volume":"31","author":"Y Wada","year":"2024","unstructured":"Wada Y, Nishi M, Yoshikawa K, Takasu C, Tokunaga T, Nakao T, Kashihara H, Yoshimoto T, Shimada M. Circulating Exosomal MicroRNA signature predicts peritoneal metastasis in patients with advanced GC. Ann Surg Oncol. 2024;31(9):5997\u20136006.","journal-title":"Ann Surg Oncol"},{"key":"4682_CR3","doi-asserted-by":"crossref","unstructured":"Matsuoka T, Yashiro M. Molecular mechanism for malignant progression of GC within the tumor microenvironment. Int J Mol Sci 2024, 25(21).","DOI":"10.3390\/ijms252111735"},{"issue":"4","key":"4682_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/cac2.12533","volume":"44","author":"KT Kim","year":"2024","unstructured":"Kim KT, Lee JE, Cheong JH, Cho I, Choi YY. Deciphering metastatic route-specific signals and their microenvironment interactions in peritoneal metastasis of GC. Cancer Commun (Lond). 2024;44(4):514\u20137.","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"4682_CR5","first-page":"515","volume":"25","author":"Y Nakamura","year":"2022","unstructured":"Nakamura Y, Kinoshita J, Yamaguchi T, Aoki T, Saito H, Hamabe-Horiike T, Harada S, Nomura S, Inaki N, Fushida S. Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: Inhibition in the migration of M2 macrophages and mast cells by Tranilast. GC. 2022;25(3):515\u201326.","journal-title":"GC"},{"issue":"1","key":"4682_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s12951-021-01127-5","volume":"19","author":"S Zheng","year":"2021","unstructured":"Zheng S, Wang J, Ding N, Chen W, Chen H, Xue M, Chen F, Ni J, Wang Z, Lin Z, et al. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for GC. J Nanobiotechnol. 2021;19(1):381.","journal-title":"J Nanobiotechnol"},{"issue":"7758","key":"4682_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41586-019-1173-8","volume":"569","author":"MA Eckert","year":"2019","unstructured":"Eckert MA, Coscia F, Chryplewicz A, Chang JW, Hernandez KM, Pan S, Tienda SM, Nahotko DA, Li G, Blazenovic I, et al. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature. 2019;569(7758):723\u20138.","journal-title":"Nature"},{"issue":"11","key":"4682_CR8","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/cas.12539","volume":"105","author":"XJ He","year":"2014","unstructured":"He XJ, Tao HQ, Hu ZM, Ma YY, Xu J, Wang HJ, Xia YJ, Li L, Fei BY, Li YQ, et al. Expression of galectin-1 in carcinoma-associated fibroblasts promotes GC cell invasion through upregulation of integrin beta1. Cancer Sci. 2014;105(11):1402\u201310.","journal-title":"Cancer Sci"},{"issue":"14","key":"4682_CR9","doi-asserted-by":"publisher","first-page":"18464","DOI":"10.18632\/aging.203295","volume":"13","author":"X You","year":"2021","unstructured":"You X, Wu J, Zhao X, Jiang X, Tao W, Chen Z, Huang C, Zheng T, Shen X. Fibroblastic galectin-1-fostered invasion and metastasis are mediated by TGF-beta1-induced epithelial-mesenchymal transition in GC. Aging. 2021;13(14):18464\u201381.","journal-title":"Aging"},{"issue":"12","key":"4682_CR10","first-page":"5535","volume":"15","author":"T Zheng","year":"2023","unstructured":"Zheng T, Qian T, Zhou H, Cheng Z, Liu G, Huang C, Dou R, Liu F, You X. Galectin-1-mediated high NCAPG expression correlates with poor prognosis in GC. Aging. 2023;15(12):5535\u201349.","journal-title":"Aging"},{"issue":"1","key":"4682_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13046-016-0449-1","volume":"35","author":"Y Chong","year":"2016","unstructured":"Chong Y, Tang D, Xiong Q, Jiang X, Xu C, Huang Y, Wang J, Zhou H, Shi Y, Wu X, et al. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through beta1 integrin-mediated upregulation of Gli1 in GC. J Exp Clin Cancer Res. 2016;35(1):175.","journal-title":"J Exp Clin Cancer Res"},{"key":"4682_CR12","doi-asserted-by":"crossref","unstructured":"Cousin JM, Cloninger MJ. The role of Galectin-1 in cancer Progression, and synthetic multivalent systems for the study of Galectin-1. Int J Mol Sci 2016, 17(9).","DOI":"10.3390\/ijms17091566"},{"issue":"15","key":"4682_CR13","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2174\/1389557521666210217093815","volume":"21","author":"NS Goud","year":"2021","unstructured":"Goud NS, Bhattacharya A. Human Galectin-1 in multiple cancers: A privileged molecular target in oncology. Mini Rev Med Chem. 2021;21(15):2169\u201386.","journal-title":"Mini Rev Med Chem"},{"issue":"2","key":"4682_CR14","first-page":"98","volume":"8","author":"S Paget","year":"1989","unstructured":"Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8(2):98\u2013101.","journal-title":"Cancer Metastasis Rev"},{"issue":"24","key":"4682_CR15","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.21.02745","volume":"40","author":"YX Gwee","year":"2022","unstructured":"Gwee YX, Chia DKA, So J, Ceelen W, Yong WP, Tan P, Ong CJ, Sundar R. Integration of genomic biology into therapeutic strategies of GC peritoneal metastasis. J Clin Oncol. 2022;40(24):2830.","journal-title":"J Clin Oncol"},{"issue":"3","key":"4682_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41388-023-02891-4","volume":"43","author":"C Wang","year":"2024","unstructured":"Wang C, Ji J, Jin Y, Sun Y, Cai Q, Jiang J, Guo L, Zhou C, Zhang J. Tumor-mesothelium HOXA11-PDGF BB\/TGF beta1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of GC. Oncogene. 2024;43(3):171\u201388.","journal-title":"Oncogene"},{"issue":"3","key":"4682_CR17","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"4682_CR18","doi-asserted-by":"crossref","unstructured":"Lewis KA, Diggs LP, Badgwell BD. Educational review: updates on therapeutic strategies for GC with peritoneal metastasis. Ann Surg Oncol 2025.","DOI":"10.1245\/s10434-025-17069-3"},{"key":"4682_CR19","doi-asserted-by":"publisher","first-page":"116235","DOI":"10.1016\/j.amjsurg.2025.116235","volume":"242","author":"Z Pelc","year":"2025","unstructured":"Pelc Z, Sedlak K, Endo Y, Van Sandick J, Gisbertz S, Pera M, Baiocchi GL, Morgagni P, Framarini M, Hoelscher A, et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) for GC with peritoneal metastasis - Joint analysis of European GASTRODATA and American National cancer database. Am J Surg. 2025;242:116235.","journal-title":"Am J Surg"},{"issue":"3","key":"4682_CR20","first-page":"701","volume":"24","author":"T Yamaguchi","year":"2021","unstructured":"Yamaguchi T, Takashima A, Nagashima K, Terashima M, Aizawa M, Ohashi M, Tanaka R, Yamada T, Kinoshita T, Matsushita H, et al. Impact of preoperative chemotherapy as initial treatment for advanced GC with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study. GC. 2021;24(3):701\u20139.","journal-title":"GC"},{"key":"4682_CR21","doi-asserted-by":"publisher","first-page":"1372956","DOI":"10.3389\/fimmu.2024.1372956","volume":"15","author":"HC Wang","year":"2024","unstructured":"Wang HC, Xia R, Chang WH, Hsu SW, Wu CT, Chen CH, Shih TC. Improving cancer immunotherapy in prostate cancer by modulating T cell function through targeting the galectin-1. Front Immunol. 2024;15:1372956.","journal-title":"Front Immunol"},{"issue":"11","key":"4682_CR22","doi-asserted-by":"publisher","first-page":"9374","DOI":"10.1021\/acs.jmedchem.4c00485","volume":"67","author":"FR Zetterberg","year":"2024","unstructured":"Zetterberg FR, Peterson K, Nilsson UJ, Andreasson Dahlgren K, Diehl C, Holyer I, Hakansson M, Khabut A, Kahl-Knutson B, Leffler H, et al. Discovery of the selective and orally available Galectin-1 inhibitor GB1908 as a potential treatment for lung cancer. J Med Chem. 2024;67(11):9374\u201388.","journal-title":"J Med Chem"},{"key":"4682_CR23","doi-asserted-by":"crossref","unstructured":"Shuster H, Funkhouser A, Allen L, Heo M, Martin JC, Edenfield WJ, Blenda AV. Exploratory assessment of Galectin-1, -3, and \u2013\u20099 in Non-Small cell lung cancer. Cancers (Basel) 2024, 16(6).","DOI":"10.3390\/cancers16061165"},{"issue":"2","key":"4682_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.7150\/thno.88917","volume":"14","author":"H Chung","year":"2024","unstructured":"Chung H, Gyu-Mi P, Na YR, Lee YS, Choi H, Seok SH. Comprehensive characterization of early-programmed tumor microenvironment by tumor-associated macrophages reveals galectin-1 as an immune modulatory target in breast cancer. Theranostics. 2024;14(2):843\u201360.","journal-title":"Theranostics"},{"key":"4682_CR25","first-page":"8","volume":"7","author":"I Yaylim","year":"2024","unstructured":"Yaylim I, Aru M, Farooqi AA, Hakan MT, Buttari B, Arese M, Saso L. Regulation of Nrf2\/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implications. Cancer Drug Resist. 2024;7:8.","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"4682_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336918.2024.2335881","volume":"18","author":"L Zhang","year":"2024","unstructured":"Zhang L, Chen W, Li X, Wang G, Xing F, Zhu X. Galectin-1 overexpression induces normal fibroblasts translate into cancer-associated fibroblasts and attenuates the sensitivity of anlotinib in lung cancer. Cell Adh Migr. 2024;18(1):1\u201311.","journal-title":"Cell Adh Migr"},{"issue":"1","key":"4682_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/jb\/mvx061","volume":"163","author":"Z Bojic-Trbojevic","year":"2018","unstructured":"Bojic-Trbojevic Z, Jovanovic Krivokuca M, Stefanoska I, Kolundzic N, Vilotic A, Kadoya T, Vicovac L. Integrin beta1 is bound to galectin-1 in human trophoblast. J Biochem. 2018;163(1):39\u201350.","journal-title":"J Biochem"},{"issue":"3","key":"4682_CR28","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10555-024-10169-8","volume":"43","author":"H Fujimoto","year":"2024","unstructured":"Fujimoto H, Yoshihara M, Rodgers R, Iyoshi S, Mogi K, Miyamoto E, Hayakawa S, Hayashi M, Nomura S, Kitami K, et al. Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination. Cancer Metastasis Rev. 2024;43(3):1037\u201353.","journal-title":"Cancer Metastasis Rev"},{"issue":"14","key":"4682_CR29","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/1873-3468.12722","volume":"591","author":"G Deng","year":"2017","unstructured":"Deng G, Qu J, Zhang Y, Che X, Cheng Y, Fan Y, Zhang S, Na D, Liu Y, Qu X. GC-derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier. FEBS Lett. 2017;591(14):2167\u201379.","journal-title":"FEBS Lett"},{"key":"4682_CR30","doi-asserted-by":"crossref","unstructured":"Chiu HC, Wu MY, Li CH, Huang SC, Yiang GT, Yen HS, Liu WL, Li CJ, Kao WY. Epithelial-Mesenchymal transition with malignant transformation leading multiple metastasis from disseminated peritoneal leiomyomatosis. J Clin Med 2018, 7(8).","DOI":"10.3390\/jcm7080207"},{"issue":"2","key":"4682_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5009\/gnl19407","volume":"15","author":"X Zhu","year":"2021","unstructured":"Zhu X, Zhou G, Ni P, Jiang X, Huang H, Wu J, Shi X, Liu J. CD31 and D2-40 contribute to peritoneal metastasis of colorectal cancer by promoting Epithelial-Mesenchymal transition. Gut Liver. 2021;15(2):273\u201383.","journal-title":"Gut Liver"},{"issue":"2","key":"4682_CR32","doi-asserted-by":"publisher","first-page":"e70166","DOI":"10.1002\/jbt.70166","volume":"39","author":"C Long","year":"2025","unstructured":"Long C, Li X, Liu J, Mo X, Zhong H, Tang W, Yu J. Exploring the role of Epithelial-Mesenchymal transition during colorectal cancer peritoneal metastasis: update on their mechanisms. J Biochem Mol Toxicol. 2025;39(2):e70166.","journal-title":"J Biochem Mol Toxicol"},{"issue":"8","key":"4682_CR33","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/cas.12445","volume":"105","author":"Y Tanizaki","year":"2014","unstructured":"Tanizaki Y, Kobayashi A, Toujima S, Shiro M, Mizoguchi M, Mabuchi Y, Yagi S, Minami S, Takikawa O, Ino K. Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment. Cancer Sci. 2014;105(8):966\u201373.","journal-title":"Cancer Sci"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04682-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04682-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04682-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:38:18Z","timestamp":1774280298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04682-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4682"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04682-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Taizhou People\u2019s Hospital Affiliated to Nanjing Medical University (2024-SRFA-050), and the study conducted according to Declaration of Helsinki guidelines. The detailed assessment procedures were explained to the patients and written informed consent was provided by all patients. Patient informed consent was obtained before surgery.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}